27.12.2012 Views

12th Congress of the European Hematology ... - Haematologica

12th Congress of the European Hematology ... - Haematologica

12th Congress of the European Hematology ... - Haematologica

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

12 th <strong>Congress</strong> <strong>of</strong> <strong>the</strong> <strong>European</strong> <strong>Hematology</strong> Association<br />

in order to evaluate whe<strong>the</strong>r abnormalities in <strong>the</strong>ir expression were<br />

associated with relevant laboratory and clinical findings. Moreover, a<br />

possible correlation was investigated between MMP positivity and<br />

altered apoptosis level, as measured by TUNEL technique, or altered<br />

proliferative activity, as evaluated by MIB-1 immunostaining. MMP-2<br />

and MMP-9 were detected on bone marrow smears by an immunoalkaline<br />

phosphatase method (streptavidin-biotin complex) using primary<br />

murine monoclonal antibodies raised against human MMP-2 (clone A-<br />

Gel VC2, NeoMarkers) and human MMP-9 (clone IIA5, NeoMarkers).<br />

In normal samples MMP-2 was detected only in occasional myeloid<br />

cells, whereas MMP-9 was expressed in some 20-30% <strong>of</strong> maturing<br />

myeloid cells. Normal CD34 + bone marrow cells did not express MMPs.<br />

MMPs were detected in almost all MDS and AML cases. In MDS <strong>the</strong> percentages<br />

<strong>of</strong> MMP-2 positive myeloid cells (median 34%, IQR 18-49%)<br />

were significantly higher than in normal controls (p

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!